FDA Releases Draft Guidance on Outsourcing Facility Definition Under Section 503B of the Federal Food, Drug, and Cosmetic Act

Summary

The Food and Drug Administration (FDA) has issued a draft guidance to clarify the definition of an outsourcing facility under Section 503B of the Federal Food, Drug, and Cosmetic Act, addressing questions from outsourcing facilities and other stakeholders about the meaning of the term.